Adebrelimab Combined With Dalpiciclib Isethionate Plus Chemotherapy for Neoadjuvant Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
A Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination With Toripalimab for Resectable Locally Advanced Oral Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Spatially Fractionated Radiotherapy With Tislelizumab and Chemotherapy for Bulky Stage III NSCLC: A Phase II Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
AK112 Combined With GAP Conversion Therapy for Locally Advanced Gallbladder Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
AI-Driven Digital Twin and Drug Simulation for Esophageal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Modified DHAP Versus Standard DHAP in Relapsed/Refractory Diffused Large B-cell Lymphoma.
- Status
- RECRUITING
- Phase
- PHASE3
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer
- Status
- RECRUITING
- Phase
- PHASE3
SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin
- Status
- COMPLETED
- Phase
- PHASE2
SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2